Xcelerating the growth, success and full potential of MedTech development and Healthcare Delivery with End to End control.
Xcelerate seeks to acquire rather than develop its technology / healthcare delivery. We understand that engineering advancements in non-medical fields often have unrealized applications in medical technology & clinical care and the silos existing between advanced engineering and medicine have been poorly bridged. Xcelerate is unique in that it was designed from inception to span the divide between initial non-medical engineering advancements and its application to clinical care.
$XCRT
https://earthsciencebeauty.com
The global skin care supplements market size is expected to reach USD 6.05 billion by 2030. The market is estimated to register a CAGR of 7.9% over the forecast period. - @YahooFinance @researchmarkets
https://finance.yahoo.com/news/increasing-competition-product-launches-drive-170000758.html
#skincareproducts
$XCRT We're thrilled to announce that the United States Patent and Trademark Office @uspto has officially published our two utility patent applications: US 18/187,352 and US 18/189,441. Read more in @OTCMarkets
https://www.otcmarkets.com/stock/XCRT/news/Xcelerate-Inc-Announces-Publication-of-its-Two-Utility-Patent-Applications?id=418647
